Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aquestive Therapeutics, Inc.

NASDAQ: AQST · Life Sciences · 12 alerts · CIK 1398733

Share price
$3.76Close, Nov 16
Market cap
$473M
Shares outstanding
125.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aquestive Therapeutics, Inc. filings on SEC EDGAR ↗

7:03 AM ET 8-K
Other 8-K Filing

Aquestive Therapeutics Other 8-K Filing

Aquestive Therapeutics has resubmitted its New Drug Application (NDA) to the FDA for Anaphylm™ (dibutepinephrine) sublingual film for the treatment of severe allergic reactions. The resubmission addresses a prior Complete Response Letter by including new human factors and pharmacokinetic data, notably reducing the median pouch-opening time from 17 seconds to 3 seconds. The company also filed an investor presentation from the H.C. Wainwright 28th Annual Global Investor Conference.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.